1. Home
  2. STRL vs RYTM Comparison

STRL vs RYTM Comparison

Compare STRL & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRL
  • RYTM
  • Stock Information
  • Founded
  • STRL 1955
  • RYTM 2008
  • Country
  • STRL United States
  • RYTM United States
  • Employees
  • STRL N/A
  • RYTM N/A
  • Industry
  • STRL Military/Government/Technical
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRL Industrials
  • RYTM Health Care
  • Exchange
  • STRL Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • STRL 3.8B
  • RYTM 3.8B
  • IPO Year
  • STRL N/A
  • RYTM 2017
  • Fundamental
  • Price
  • STRL $179.42
  • RYTM $60.72
  • Analyst Decision
  • STRL Strong Buy
  • RYTM Strong Buy
  • Analyst Count
  • STRL 2
  • RYTM 12
  • Target Price
  • STRL $185.00
  • RYTM $75.42
  • AVG Volume (30 Days)
  • STRL 1.1M
  • RYTM 659.5K
  • Earning Date
  • STRL 05-05-2025
  • RYTM 05-07-2025
  • Dividend Yield
  • STRL N/A
  • RYTM N/A
  • EPS Growth
  • STRL 78.58
  • RYTM N/A
  • EPS
  • STRL 8.56
  • RYTM N/A
  • Revenue
  • STRL $2,106,345,000.00
  • RYTM $136,863,000.00
  • Revenue This Year
  • STRL N/A
  • RYTM $43.84
  • Revenue Next Year
  • STRL $7.82
  • RYTM $65.62
  • P/E Ratio
  • STRL $20.99
  • RYTM N/A
  • Revenue Growth
  • STRL 4.84
  • RYTM 48.88
  • 52 Week Low
  • STRL $93.50
  • RYTM $35.17
  • 52 Week High
  • STRL $206.07
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • STRL 77.88
  • RYTM 50.15
  • Support Level
  • STRL $143.20
  • RYTM $62.69
  • Resistance Level
  • STRL $154.97
  • RYTM $65.53
  • Average True Range (ATR)
  • STRL 7.47
  • RYTM 2.84
  • MACD
  • STRL 3.41
  • RYTM -0.34
  • Stochastic Oscillator
  • STRL 91.86
  • RYTM 23.94

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions. .

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: